FERKOLJ, I.; IHAN, A.; MARKOVIC, S.; VECERIC, Z.; POHAR, M. Infliximab Reduces the Number of Activated Mucosal Lymphocytes in Patients with Crohn’s Disease. Journal of Gastrointestinal and Liver Diseases, [S. l.], v. 15, n. 3, p. 231–235, 2006. Disponível em: https://www.jgld.ro/jgld/index.php/jgld/article/view/2006.3.4. Acesso em: 9 aug. 2026.